Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amryt Pharma Plc ADR (NQ: AMYT )

6.990 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.990
Bid (Size) 6.900 (2)
Ask (Size) 8.930 (1)
Prev. Close 6.990
Today's Range 6.990 - 6.990
52wk Range 5.610 - 12.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Filsuvez's European Approval Adds Growth Driver For Amryt Pharma
 
Via Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-34.92%
-34.92%
1 Month
-10.73%
-10.73%
3 Month
-10.84%
-10.84%
6 Month
-35.46%
-35.46%
1 Year
-41.56%
-41.56%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Amryt Pharma Plc (NASDAQ:AMYT) Shareholder Notice: Investigation Concerning Possible Wrongdoing
Via SBWire
Recap: Amryt Pharma Q1 Earnings
Via Benzinga
Amryt Shares Trading Higher As EMA Endorses Approval Of Filsuvez In Genetic Skin Disease
Via Benzinga
Amryt Posts Long-Term Safety, Efficacy Mycapssa Data In Acromegaly Patients
Via Benzinga
Recap: Amryt Pharma Q4 Earnings
Via Benzinga
55 Biggest Movers From Friday
Via Benzinga
Amryt Pharma Plc (NASDAQ:AMYT) Investor Notice: Investigation over Possible Violations of Securities Laws
Via SBWire
Amryt Pharma's Q4 FY21 Sales, FY22 Guidance Shy Of Street Consensus
Via Benzinga
Amryt Shares Fall After Oleogel-S10 EMA Regulatory Update
Via Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Via Benzinga
Earnings Scheduled For March 9, 2022
Via Benzinga
A Preview Of Amryt Pharma's Earnings
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
FDA Rejects Amryt Pharma's Oleogel-S10 Application For Skin Blistering Disorder
Via Benzinga
67 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
42 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Via Talk Markets
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.